Yes I seen something of those and reported here some documents you point too, until we can get one approval on the use of Leronlimab whether it be HIV, COVID-19 or some other indication I feel we are battling a two-headed beast in the form of FDA and BP. When there is Billions to be lost because of the approval of Leronlimab you can bet they will not go without a serious long battle. I will always be in favor of a buyout even if its a lost less than we think the company is worth, just for the two-headed beast battle ahead.